Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05876858 · ClinicalTrials.gov registry record · Early Phase 1
EXPLORER Total Body PET/CT Imaging for Myofascial Pain
A Early Phase 1 study of Myofascial Pain, sponsored by University of California, Davis.
- Active
- Registry status
- Early Phase 1
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT05876858: Active Early Phase 1 study of Myofascial Pain, sponsored by University of California, Davis.
NCT05876858 is a Early Phase 1 study of Myofascial Pain that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 53 participants, below the 67-participant average among 8 other Myofascial Pain trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05876858, a Early Phase 1 study of Myofascial Pain, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of this study is to establish novel measures derived from Total-body-Positron Emission Tomography/Computed Tomography (TB-PET/CT) as quantitative biomarkers for the investigation of myofascial pain. The TB-PET/CT assessed measures are those reflective of myofascial tissue metabolism, perfusion, and fatty infiltration.
Primary Outcome
Our primary outcome measure is the NIH Helping to End Addiction Long-term (HEAL) measure: PEG (Pain, Enjoyment, General Activity) score, which quantitatively evaluates pain intensity and interference. This is a score from 0 to 10.
Conditions Studied
Interventions
- DRUG 18F-FDG
- DRUG 11C-butanol
Study Locations (1)
California
- University of California Davis Health - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2023-06-13 |
| Est. Completion | 2027-09 |
| Phase | Early Phase 1 |
What the registry record for NCT05876858 still lists
NCT05876858 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 67-participant average among 8 other Myofascial Pain trials with a reported enrollment target (21% lower).
The record links to 1 condition, with Myofascial Pain appearing as the primary indexed condition, and to 2 interventions - of which 18F-FDG is the first listed.
NCT05876858 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05876858 about?
NCT05876858 is a clinical study titled "EXPLORER Total Body PET/CT Imaging for Myofascial Pain". The main objective of this study is to establish novel measures derived from Total-body-Positron Emission Tomography/Computed Tomography (TB-PET/CT) as quantitative biomarkers for the investigation of myofascial pain. The TB-PET/CT assessed measures are those reflective of myofascial tissue metaboli...
What is the current status of trial NCT05876858?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 53 participants. The study started on 2023-06-13. Estimated completion is 2027-09.
What conditions does trial NCT05876858 study?
This clinical trial studies the following conditions: Myofascial Pain.
What interventions are being tested in trial NCT05876858?
The interventions under investigation include: 18F-FDG (DRUG), 11C-butanol (DRUG).
Who is sponsoring clinical trial NCT05876858?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05876858 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myofascial Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05876858's enrollment target sits among peer trials
53 5th of 8 higher than 4 of 8 other Myofascial Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myofascial Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multi-modal Imaging of Myofascial Pain - Phase 2
RECRUITING · NA
-
Magnetic Resonance Elastography to Monitor Response to Manual Therapy in Myofascial Pain
RECRUITING · NA
-
Evaluation of a Novel Class of Objective Myofascial Pain Assessments
ACTIVE NOT RECRUITING
-
Multi-modal Imaging of Myofascial Pain
ACTIVE NOT RECRUITING · NA
-
BBTI vs PSR in Musculoskeletal Orofacial Pain Adults
COMPLETED · NA
-
Ultrasound Imaging for Myofascial Pain
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI